Cargando…

Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details

BACKGROUND: Cystic fibrosis (CF) is a life-threatening genetic disorder, characterized by chronic microbial lung infections due to abnormally viscous mucus secretions within airways. The clinical management of CF typically involves regular respiratory-tract cultures in order to identify pathogens an...

Descripción completa

Detalles Bibliográficos
Autores principales: Feigelman, Rounak, Kahlert, Christian R., Baty, Florent, Rassouli, Frank, Kleiner, Rebekka L., Kohler, Philipp, Brutsche, Martin H., von Mering, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303297/
https://www.ncbi.nlm.nih.gov/pubmed/28187782
http://dx.doi.org/10.1186/s40168-017-0234-1
_version_ 1782506685086040064
author Feigelman, Rounak
Kahlert, Christian R.
Baty, Florent
Rassouli, Frank
Kleiner, Rebekka L.
Kohler, Philipp
Brutsche, Martin H.
von Mering, Christian
author_facet Feigelman, Rounak
Kahlert, Christian R.
Baty, Florent
Rassouli, Frank
Kleiner, Rebekka L.
Kohler, Philipp
Brutsche, Martin H.
von Mering, Christian
author_sort Feigelman, Rounak
collection PubMed
description BACKGROUND: Cystic fibrosis (CF) is a life-threatening genetic disorder, characterized by chronic microbial lung infections due to abnormally viscous mucus secretions within airways. The clinical management of CF typically involves regular respiratory-tract cultures in order to identify pathogens and to guide treatment. However, culture-based methods can miss atypical or slow-growing microbes. Furthermore, the isolated microbes are often not classified at the strain level due to limited taxonomic resolution. RESULTS: Here, we show that untargeted metagenomic sequencing of sputum DNA can provide valuable information beyond the possibilities of culture-based diagnosis. We sequenced the sputum of six CF patients and eleven control samples (including healthy subjects and chronic obstructive pulmonary disease patients) without prior depletion of human DNA or cell size selection, thus obtaining the most unbiased and comprehensive characterization of CF respiratory tract microbes to date. We present detailed descriptions of the CF and healthy lung microbiome, reconstruct near complete pathogen genomes, and confirm that the CF lungs consistently exhibit reduced microbial diversity. Crucially, the obtained genomic sequences enabled a detailed identification of the exact pathogen strain types, when analyzed in conjunction with existing multi-locus sequence typing databases. We also detected putative pathogenicity islands and indicators of antibiotic resistance, in good agreement with independent clinical tests. CONCLUSIONS: Unbiased sputum metagenomics provides an in-depth profile of the lung pathogen microbiome, which is complementary to and more detailed than standard culture-based reporting. Furthermore, functional and taxonomic features of the dominant pathogens, including antibiotics resistances, can be deduced—supporting accurate and non-invasive clinical diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0234-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5303297
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53032972017-02-15 Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details Feigelman, Rounak Kahlert, Christian R. Baty, Florent Rassouli, Frank Kleiner, Rebekka L. Kohler, Philipp Brutsche, Martin H. von Mering, Christian Microbiome Research BACKGROUND: Cystic fibrosis (CF) is a life-threatening genetic disorder, characterized by chronic microbial lung infections due to abnormally viscous mucus secretions within airways. The clinical management of CF typically involves regular respiratory-tract cultures in order to identify pathogens and to guide treatment. However, culture-based methods can miss atypical or slow-growing microbes. Furthermore, the isolated microbes are often not classified at the strain level due to limited taxonomic resolution. RESULTS: Here, we show that untargeted metagenomic sequencing of sputum DNA can provide valuable information beyond the possibilities of culture-based diagnosis. We sequenced the sputum of six CF patients and eleven control samples (including healthy subjects and chronic obstructive pulmonary disease patients) without prior depletion of human DNA or cell size selection, thus obtaining the most unbiased and comprehensive characterization of CF respiratory tract microbes to date. We present detailed descriptions of the CF and healthy lung microbiome, reconstruct near complete pathogen genomes, and confirm that the CF lungs consistently exhibit reduced microbial diversity. Crucially, the obtained genomic sequences enabled a detailed identification of the exact pathogen strain types, when analyzed in conjunction with existing multi-locus sequence typing databases. We also detected putative pathogenicity islands and indicators of antibiotic resistance, in good agreement with independent clinical tests. CONCLUSIONS: Unbiased sputum metagenomics provides an in-depth profile of the lung pathogen microbiome, which is complementary to and more detailed than standard culture-based reporting. Furthermore, functional and taxonomic features of the dominant pathogens, including antibiotics resistances, can be deduced—supporting accurate and non-invasive clinical diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40168-017-0234-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-10 /pmc/articles/PMC5303297/ /pubmed/28187782 http://dx.doi.org/10.1186/s40168-017-0234-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Feigelman, Rounak
Kahlert, Christian R.
Baty, Florent
Rassouli, Frank
Kleiner, Rebekka L.
Kohler, Philipp
Brutsche, Martin H.
von Mering, Christian
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
title Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
title_full Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
title_fullStr Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
title_full_unstemmed Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
title_short Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
title_sort sputum dna sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303297/
https://www.ncbi.nlm.nih.gov/pubmed/28187782
http://dx.doi.org/10.1186/s40168-017-0234-1
work_keys_str_mv AT feigelmanrounak sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT kahlertchristianr sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT batyflorent sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT rassoulifrank sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT kleinerrebekkal sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT kohlerphilipp sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT brutschemartinh sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails
AT vonmeringchristian sputumdnasequencingincysticfibrosisnoninvasiveaccesstothelungmicrobiomeandtopathogendetails